Palivizumab e virus respiratorio sinciziale: una panoramica. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 12, n. 3S, p. 3–16, 2011. DOI: 10.7175/fe.v12i3S.984. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/984. Acesso em: 29 oct. 2025.